PHASE-II EVALUATION OF MITOXANTRONE PLUS CISPLATINUM IN PATIENTS WITH ADVANCED BREAST-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY

被引：5
作者：
ATIBA, JO
GREEN, SJ
HYNES, HE
OSBORNE, CK
MILLER, TP
DAVIDNER, M
机构：
[1] UNIV CALIF IRVINE,COLL MED,IRVINE,CA 92717
[2] SW ONCOL GRP,CTR STAT,SEATTLE,WA
[3] WICHITA CCOP,WICHITA,KS
[4] UNIV TEXAS,HLTH SCI CTR,SAN ANTONIO,TX
[5] UNIV ARIZONA,ARIZONA CANC CTR,TUCSON,AZ 85724
[6] KANSAS CITY CLIN ONCOL PROGRAM,KANSAS CITY,MO
来源：
INVESTIGATIONAL NEW DRUGS | 1994年 / 12卷 / 02期
关键词：
CISPLATINUM; MITOXANTRONE; BREAST CANCER; PHASE I-II TRIAL;
D O I：
10.1007/BF00874442
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The Southwest Oncology Group studied the response rate and toxicity of mitoxantrone (7.5 or 10 mg/m(2) to 12.0 mg/m(2)) and cis-platinum (100 mg/m(2)) in 30 patients with advanced breast cancer as second-line therapy. There were 2 partial responses in 29 eligible patients. Toxicity was considerable, with 27 patients having grade 3 or 4 toxicity. Grade 3-4 toxicity included vomiting, thrombocytopenia, granulocytopenia, leukopenia and anemia. The combination of mitoxantrone plus cis-platinum has minimal activity as second-line therapy in metastatic breast cancer.
引用
收藏
页码：129 / 132
页数：4
相关论文
共 50 条
[41]   PHASE-II STUDY OF HIGH-DOSE TOREMIFENE IN ADVANCED BREAST-CANCER PROGRESSING DURING TAMOXIFENE TREATMENT [J].
JONSSON, PE ;
MALMBERG, M ;
BERGLJUNG, L ;
INGVAR, C ;
ERICSSON, M ;
RYDEN, S ;
NILSSON, I ;
TERJE, IJ .
ANTICANCER RESEARCH, 1991, 11 (02) :873-876
[42]   PHASE-II TRIAL OF 5-FLUOROURACIL AND FOLINIC ACID IN THE TREATMENT OF ADVANCED BREAST-CANCER [J].
FINE, S ;
ERLICHMAN, C ;
KAIZER, L ;
WARR, D ;
GADALLA, T .
BREAST CANCER RESEARCH AND TREATMENT, 1994, 30 (02) :205-209
[43]   PHASE-II TRIAL OF DOXORUBICIN AND TRIFLUOPERAZINE IN METASTATIC BREAST-CANCER [J].
BUDD, GT ;
BUKOWSKI, RM ;
LICHTIN, A ;
BAUER, L ;
VANKIRK, P ;
GANAPATHI, R .
INVESTIGATIONAL NEW DRUGS, 1993, 11 (01) :75-79
[44]   TOPICALLY APPLIED MILTEFOSINE (HEXADECYLPHOSPHOCHOLINE) IN PATIENTS WITH SKIN-METASTASIZED BREAST-CANCER - A PHASE-II STUDY [J].
UNGER, C ;
HERRMANN, R ;
BERDEL, WE ;
KLEEBERG, UR ;
GATZEMEIER, U ;
ILLIGER, HJ ;
WANDER, HE ;
WESTERHAUSEN, M ;
BECHER, R ;
BREMER, K ;
RIECHE, K ;
ESSERS, U ;
QUEISSER, W ;
HEIDEMANN, E ;
FIEBIG, HH ;
POSSINGER, K ;
JOURDAINMADL, B ;
HEIM, ME ;
EDLER, L .
ONKOLOGIE, 1993, 16 (03) :170-173
[45]   CARDIOTOXICITY EVALUATION IN PATIENTS TREATED WITH A MITOXANTRONE COMBINATION AS ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER [J].
FOUNTZILAS, G ;
AFTHONIDIS, D ;
GELERIS, P ;
SALEM, N ;
KOTTAS, G ;
HALKIDIS, C ;
APOSTOLIDIS, P ;
BEER, M ;
TOURKANTONIS, A .
ANTICANCER RESEARCH, 1992, 12 (01) :231-234
[46]   COMBINATION OF IDARUBICIN AND CYCLOPHOSPHAMIDE ADMINISTERED ORALLY IN UNTREATED POSTMENOPAUSAL BREAST-CANCER PATIENTS - A PHASE-II STUDY [J].
KOLARIC, K ;
MECHL, Z .
ONCOLOGY, 1991, 48 (02) :93-96
[47]   MODULATION OF CANCER ENDOCRINE THERAPY BY MELATONIN - A PHASE-II STUDY OF TAMOXIFEN PLUS MELATONIN IN METASTATIC BREAST-CANCER PATIENTS PROGRESSING UNDER TAMOXIFEN ALONE [J].
LISSONI, P ;
BARNI, S ;
MEREGALLI, S ;
FOSSATI, V ;
CAZZANIGA, M ;
ESPOSTI, D ;
TANCINI, G .
BRITISH JOURNAL OF CANCER, 1995, 71 (04) :854-856
[48]   Dose intensification of mitoxantrone in combination with paclitaxel in advanced breast cancer: a phase II study [J].
Di Costanzo, F ;
Sdrobolini, A ;
Manzione, L ;
Bilancia, D ;
Acito, L ;
Gasperoni, S ;
Valenti, L ;
Fioriti, L ;
Angiona, S ;
Giustini, L .
BREAST CANCER RESEARCH AND TREATMENT, 1999, 54 (02) :165-171
[49]   NEOADJUVANT CHEMOTHERAPY BY MCF (MITOXANTRONE, CYCLOPHOSPHAMIDE, FLUOROURACIL) IN 40 PATIENTS WITH INTERMEDIATE STAGE OPERABLE BREAST-CANCER - 1ST RESULTS OF A PHASE-II STUDY [J].
LEMAIRE, M ;
FOCAN, C ;
DESAIVE, C ;
CLOSONDEJARDIN, MT ;
DUVIVIER, J ;
FRIEDMAN, V ;
BAUGNETMAHIEU, L ;
PARIDAENS, R .
BULLETIN DU CANCER, 1992, 79 (09) :883-891
[50]   Dose intensification of mitoxantrone in combination with paclitaxel in advanced breast cancer: a phase II study [J].
Francesco Di Costanzo ;
Andrea Sdrobolini ;
Luigi Manzione ;
Domenico Bilancia ;
Luigi Acito ;
Silvia Gasperoni ;
Lanfranco Valenti ;
Lorella Fioriti ;
Sabrina Angiona ;
Lucio Giustini .
Breast Cancer Research and Treatment, 1999, 54 :165-171
12345